EBS
NYSE · Biotechnology
Emergent Biosolutions Inc
$8.47
+0.24 (+2.92%)
Open$8.99
Previous Close$8.23
Day High$9.32
Day Low$7.53
52W High$14.06
52W Low$4.72
Volume—
Avg Volume776.0K
Market Cap481.50M
P/E Ratio9.15
EPS$0.83
SectorBiotechnology
Analyst Ratings
Strong Buy
6 analysts
Price Target
+219.7% upside
Current
$8.47
$8.47
Target
$27.08
$27.08
$18.81
$27.08 avg
$37.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 744.84M | 854.27M | 356.03M |
| Net Income | 52.74M | 54.44M | -80,261,545 |
| Profit Margin | 7.1% | 6.7% | -22.5% |
| EBITDA | 207.74M | 226.35M | -95,339,299 |
| Free Cash Flow | — | — | -67,766,487 |
| Rev Growth | -12.8% | -12.8% | +7.9% |
| Debt/Equity | 1.09 | 1.09 | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |